Judges in two separate cases have ruled in favor of pharma giant Johnson & Johnson, overturning large financial judgments awarded to plaintiffs who believe the company's Baby Powder and Shower to Shower powder products caused their ovarian cancer. One award was to a California woman for $417 million, and another was to an Alabama woman for $72 million.